XTX Topco’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
+7,859
New +$1.06M 0.02% 1585
2026
Q1
Sell
-3,794
Closed -$463K 4466
2025
Q4
$463K Sell
3,794
-4,489
-54% -$515K 0.01% 1676
2025
Q3
$830K Sell
8,283
-62,136
-88% -$5.6M 0.04% 692
2025
Q2
$5.84M Buy
+70,419
New +$5.62M 0.24% 52

Other funds holding XBI

XTX Topco's XBI Position: Q2 2026 in Review

XTX Topco opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 7,859 shares worth $1.24M. The stake represents 0.02% of the portfolio and ranks #1585 among its holdings. This is a return to the name: XTX Topco previously reported a position in XBI as recently as Q4 2025.

XTX Topco first reported a position in XBI in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.84M in Q2 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • XTX Topco held 7,859 shares of State Street SPDR S&P Biotech ETF worth $1.24M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new XTX Topco position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1585 holding.
  • XTX Topco first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • XTX Topco's State Street SPDR S&P Biotech ETF position peaked at $5.84M in Q2 2025.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.